Washington, November 17 (RHC)-- U.S. President Donald Trump has nominated Alex Azar, a former top executive of pharmaceutical giant Eli Lilly, to lead the Department of Health and Human Services. The post has been vacant since the resignation of Tom Price.
Public Citizen’s Robert Weissman criticized the nomination, saying: “Tom Price supported Big Pharma in the U.S. Congress. Now apparently Trump has decided to cut out the middleman and let a pharmaceutical executive literally run the federal department that protects the health of all Americans.”
Donald Trump Nominates Former Drug Company Executive as HHS Secretary
Related Articles
Commentaries
MAKE A COMMENT
All fields requiredMore Views
- Cuba could become a BRICS partner country in 2025, according to Russia
- The harsh account of a U.S. doctor who broke down in tears before a UN committee explaining the situation in Gaza
- Brazil’s former defense minister arrested in attempted coup probe
- Cuba will defend its sovereign right to an independent, socialist future, committed to peace, sustainable development, social justice and solidarity
- Police arrest faculty and students demanding New York University divest from Israel’s wars and occupations